HOME >> MEDICINE >> NEWS
Nighttime Asthma Squeezes School Attendance

Children suffering nighttime asthma attacks, which can be as severe as daytime attacks, miss school and cause parents to miss work, and may also perform more poorly in school, says a study by Hopkins asthma researcher Gregory Diette, M.D., presented at the American Thoracic Society annual meeting today.

"Nighttime asthma may be a marker that asthma is out of control, or it may be a different phenomenon, caused by different triggers," said Diette. "If asthma disrupts the amount or quality of sleep, the children don't function as well the next day. And parents may suffer when they lose sleep to care for their sick children."

Diette and his colleagues surveyed 400 parents whose children suffered asthma and were treated by doctors at managed care clinics. During the month leading up to the survey, nocturnal asthma attacks awakened 56 percent of the children one or more nights, and 30 percent missed one or more days of school because of their asthma. Thirty-six percent of the parents felt nocturnal attacks hindered their child's school performance.

And parents suffered as well -- 30 percent of them reported missing work or other important activities on days following their children's nighttime tossing and turning.

Diette and his colleagues at Hopkins in Baltimore and researchers at Merck and Co., West Point, Pa., also found that children who woke up more often tended to miss more school and their parents tended to miss more work. This positive correlation held even when the researchers took into account the severity of the child's daytime symptoms and reliance on medication.

"No matter how severe the child's daytime symptoms, the more frequently they woke up at night, the more likely they were to miss school," said Diette. "The explanation may be as simple as a sleep disturbance interfering with routine daytime functioning."

One reason for nighttime asthma may be the environment, says Diette. Triggers l
'"/>

Contact: Brian Vastag
bvastag@jhmi.edu
410-955-8665
Johns Hopkins Medical Institutions
25-Apr-1999


Page: 1 2

Related medicine news :

1. Nighttime is the right time to prevent preterm labor with aspirin
2. Research guides medication choices for young Asthma patients
3. Asthma symptoms reduced among children whose schools provided asthma medication
4. $7 million grant continues Asthma Clinical Research Network efforts
5. Asthma at school is disruptive to routine underdiagnosed, often poorly understood, survey suggest
6. Asthma severity is variable and unpredictable
7. Asthma, guide for physicians, published
8. Asthma researchers present new results, new perspectives on the disease
9. Results of NUVANCE (IL-4 receptor) in Phase I/II study in asthma patients featured at AAAAI Late-Breaker Abstract and Asthma Therapy Sessions
10. Asthma In American Indian And Alaska Native Children
11. ALA/ATS Meeting Explores Gender Differences In Smoking And Lung Transplant Outcomes And Heart Attack Risk From Asthma Medication

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Nighttime Asthma Squeezes School Attendance

(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... The Jerry ... at The ACE Club and Green Valley Country Club in Lafayette Hill, PA. Over ... raised more than $13.5 million for programs and services designed to support patients and ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... the release of version 5.2 of the FirstSpirit Content Management System with new ... With the new version of FirstSpirit, companies will be well on their way ...
(Date:9/1/2015)... ... September 01, 2015 , ... The FSH Society , the Massachusetts-based charity ... (FSHD), will be the beneficiary of a collection of fundraising events this fall. From ... of the FSH Society and further FSHD research. , The list of ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... and Qualification of Laboratory Instruments in accordance with GMP requirements“ , featuring Ed ... on October 6th, 2015 at 11:00 EDT (15:00 GMT). , Calibration, qualification, ...
(Date:9/1/2015)... York, NY (PRWEB) , ... September 01, 2015 ... ... that, to date, more than 1,500 investor-families have received permanent green cards (I-829 ... EB-5 projects. , The I-829 petition is the final step of the EB-5 ...
Breaking Medicine News(10 mins):Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 2Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 3Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 2Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 3Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 2Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 3Health News:Live Webinar from Pharmaceutical Technology and METTLER TOLEDO on Calibration and Qualification of Laboratory Instruments 2Health News:CanAm Enterprises Reaches Another Milestone with More Than 1,500 I-829 Petition Approvals 2
(Date:9/1/2015)... , Sept. 1, 2015  Abbott (NYSE: ABT ... a multi-center, randomized trial comparing the safety and effectiveness ... ® , Abbott,s market-leading, permanent drug eluting stent. ... Japan and enrolled 400 people with ... disease. The results will be featured at a late-breaking ...
(Date:9/1/2015)... , Sept. 1, 2015  Valeant Pharmaceuticals International, ... today announced that its affiliate has entered into ... was granted an exclusive license to develop and ... IL-17 receptor monoclonal antibody in development for patients ... the agreement, Valeant will hold the exclusive rights ...
(Date:8/31/2015)... Pepperl+Fuchs, a world leader in process ... leading provider of HART protocol devices. The move ... its integrated solutions offerings and strengthen its position ... are pleased to add the MACTek WirelessHART product ... Bolin , Pepperl+Fuchs, executive vice president of the ...
Breaking Medicine Technology:Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 2Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 3Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 4Valeant And AstraZeneca To Partner On Brodalumab 2Valeant And AstraZeneca To Partner On Brodalumab 3Valeant And AstraZeneca To Partner On Brodalumab 4
Cached News: